157 related articles for article (PubMed ID: 33392483)
1. Circulating argonaute-bound microRNA-126 reports vascular dysfunction and treatment response in acute and chronic kidney disease.
Scullion KM; Vliegenthart ADB; Rivoli L; Oosthuyzen W; Farrah TE; Czopek A; Webb DJ; Hunter RW; Bailey MA; Dhaun N; Dear JW
iScience; 2021 Jan; 24(1):101937. PubMed ID: 33392483
[TBL] [Abstract][Full Text] [Related]
2. The effect of renal dysfunction and haemodialysis on circulating liver specific miR-122.
Rivoli L; Vliegenthart AD; de Potter CM; van Bragt JJ; Tzoumas N; Gallacher P; Farrah TE; Dhaun N; Dear JW
Br J Clin Pharmacol; 2017 Mar; 83(3):584-592. PubMed ID: 27650800
[TBL] [Abstract][Full Text] [Related]
3. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease.
Wang H; Peng W; Shen X; Huang Y; Ouyang X; Dai Y
Braz J Med Biol Res; 2012 Dec; 45(12):1308-14. PubMed ID: 23070235
[TBL] [Abstract][Full Text] [Related]
5. Insufficient sleep is associated with a pro-atherogenic circulating microRNA signature.
Hijmans JG; Levy M; Garcia V; Lincenberg GM; Diehl KJ; Greiner JJ; Stauffer BL; DeSouza CA
Exp Physiol; 2019 Jun; 104(6):975-982. PubMed ID: 31016755
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of microRNA in chronic kidney disease: patterns in acute and chronic exercise.
Van Craenenbroeck AH; Ledeganck KJ; Van Ackeren K; Jürgens A; Hoymans VY; Fransen E; Adams V; De Winter BY; Verpooten GA; Vrints CJ; Couttenye MM; Van Craenenbroeck EM
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(12):H2008-16. PubMed ID: 26475583
[TBL] [Abstract][Full Text] [Related]
7. Impaired vascular function contributes to exercise intolerance in chronic kidney disease.
Van Craenenbroeck AH; Van Craenenbroeck EM; Van Ackeren K; Hoymans VY; Verpooten GA; Vrints CJ; Couttenye MM
Nephrol Dial Transplant; 2016 Dec; 31(12):2064-2072. PubMed ID: 27540045
[TBL] [Abstract][Full Text] [Related]
8. Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis.
Hakroush S; Tampe D; Ströbel P; Korsten P; Tampe B
Front Immunol; 2021; 12():737708. PubMed ID: 34759920
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-92a Mediates Endothelial Dysfunction in CKD.
Shang F; Wang SC; Hsu CY; Miao Y; Martin M; Yin Y; Wu CC; Wang YT; Wu G; Chien S; Huang HD; Tarng DC; Shiu YT; Cheung AK; Huang PH; Chen Z; Shyy JY
J Am Soc Nephrol; 2017 Nov; 28(11):3251-3261. PubMed ID: 28696247
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-100 Suppresses Chronic Vascular Inflammation by Stimulation of Endothelial Autophagy.
Pankratz F; Hohnloser C; Bemtgen X; Jaenich C; Kreuzaler S; Hoefer I; Pasterkamp G; Mastroianni J; Zeiser R; Smolka C; Schneider L; Martin J; Juschkat M; Helbing T; Moser M; Bode C; Grundmann S
Circ Res; 2018 Feb; 122(3):417-432. PubMed ID: 29208678
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs (miR-126, miR-197, and miR-223) are associated with chronic kidney disease among elderly survivors of the Great East Japan Earthquake.
Fujii R; Yamada H; Yamazaki M; Munetsuna E; Ando Y; Ohashi K; Ishikawa H; Shimoda H; Sakata K; Ogawa A; Kobayashi S; Suzuki K;
BMC Nephrol; 2019 Dec; 20(1):474. PubMed ID: 31864304
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-142-3p improves vascular relaxation in uremia.
Kétszeri M; Kirsch A; Frauscher B; Moschovaki-Filippidou F; Mooslechner AA; Kirsch AH; Schabhuettl C; Aringer I; Artinger K; Pregartner G; Ekart R; Breznik S; Hojs R; Goessler W; Schilcher I; Müller H; Obermayer-Pietsch B; Frank S; Rosenkranz AR; Eller P; Eller K
Atherosclerosis; 2019 Jan; 280():28-36. PubMed ID: 30453118
[TBL] [Abstract][Full Text] [Related]
13. Circulating MicroRNA-125b Predicts the Presence and Progression of Uremic Vascular Calcification.
Chao CT; Liu YP; Su SF; Yeh HY; Chen HY; Lee PJ; Chen WJ; Lee YM; Huang JW; Chiang CK; Hung KY; Chen HW
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1402-1414. PubMed ID: 28522697
[TBL] [Abstract][Full Text] [Related]
14. Concordant changes of plasma and kidney microRNA in the early stages of acute kidney injury: time course in a mouse model of bilateral renal ischemia-reperfusion.
Bellinger MA; Bean JS; Rader MA; Heinz-Taheny KM; Nunes JS; Haas JV; Michael LF; Rekhter MD
PLoS One; 2014; 9(4):e93297. PubMed ID: 24695114
[TBL] [Abstract][Full Text] [Related]
15. Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial.
Lee MS; Lee FY; Chen YL; Sung PH; Chiang HJ; Chen KH; Huang TH; Chen YL; Chiang JY; Yin TC; Chang HW; Yip HK
Oncotarget; 2017 Mar; 8(11):17750-17762. PubMed ID: 28148896
[TBL] [Abstract][Full Text] [Related]
16. Renal microRNA- and RNA-profiles in progressive chronic kidney disease.
Rudnicki M; Perco P; D Haene B; Leierer J; Heinzel A; Mühlberger I; Schweibert N; Sunzenauer J; Regele H; Kronbichler A; Mestdagh P; Vandesompele J; Mayer B; Mayer G
Eur J Clin Invest; 2016 Mar; 46(3):213-26. PubMed ID: 26707063
[TBL] [Abstract][Full Text] [Related]
17. Circulating human microRNA biomarkers of oxalic acid-induced acute kidney injury.
Shihana F; Joglekar MV; Raubenheimer J; Hardikar AA; Buckley NA; Seth D
Arch Toxicol; 2020 May; 94(5):1725-1737. PubMed ID: 32086547
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies.
Chan TM; Frampton G; Jayne DR; Perry GJ; Lockwood CM; Cameron JS
Am J Kidney Dis; 1993 Sep; 22(3):387-92. PubMed ID: 8372833
[TBL] [Abstract][Full Text] [Related]
19. Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD).
Chen NX; Kiattisunthorn K; O'Neill KD; Chen X; Moorthi RN; Gattone VH; Allen MR; Moe SM
PLoS One; 2013; 8(5):e64558. PubMed ID: 23717629
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease.
Fourdinier O; Glorieux G; Brigant B; Diouf M; Pletinck A; Vanholder R; Choukroun G; Verbeke F; Massy ZA; Metzinger-Le Meuth V; Metzinger L; Group-EUTox OBOTEUTW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
